Clothes Create Chronology

Clothes Create Chronology

My husband and I are in Las Vegas at the moment, getting together with some old friends. This is the second time we’ve met up with them here in Vegas, and today we were trying to decide how long ago our last visit took place. Was it three years ago or four? None of us could pinpoint the date, but I was able to establish the timeline by remembering what clothes I’d been wearing.

It’s a talent a lot of women share: the ability to remember the clothes we wore on every occasion. When planning a 50th birthday party for my husband Wade, I sat with his sister looking at slides to show at the party. As we tried to figure out when each was taken, we discovered it was easiest to establish dates by looking at how we were dressed. “I remember buying that suit for a friend’s wedding who was married a year before us,” I’d say as I flipped through. We women love our clothes and tend to remember how we felt wearing them.

Our memories revolve around them, and they help create a chronology.

Why is this so? I think it’s partly because women are by nature creative creatures, and clothes are a natural creative outlet. I’ve always enjoyed being able to express my creativity through my clothes, even when I was working in corporate and limited to power suits. During that period, I purposefully kept my look fairly conservative. In the male-dominated world of mining and agriculture where I worked, it was a liability to express femininity. In a subtle way, to be female meant I was expressing weakness – that I needed to be protected and wasn’t an equal member of the team. I denied my natural self and acted out the male characteristics I felt would ensure my inclusion and success.

When I left that life behind, I suddenly found myself wanting to reclaim my suppressed femininity, trading in my suits for flowing skirts and long earrings. I so doing, I came to realize that our feminine power should be encouraged, not buried. We need to reclaim our position as full-fledged partners to allow us to bring forth our skills and talents to the workplace.

For a number of reasons, the world would be a better place with more women in senior positions in businesses and organizations. The diversity would benefit everyone, as the female energy would provide a nice balance to all the male testosterone in the boardroom. Women are by nature less impulsive and more risk averse; it’s kind of like those hunters who would have kept killing the animals if the women back at the cave hadn’t said, “Hey, we have enough food. Let the herd replenish.”

In fact, companies with more women in senior positions tend have better results and are exposed to less risk. A recent study cited in the New York Times found that male traders in a market upswing experienced a rise in testosterone similar to that found in male athletes; as a result, they lose sight of external signals and take unnecessary risks. This irrational behavior could have exaggerated the stock market bubble in today’s world, just as it could have depleted the herds eons ago. Both then and now, having the women there to say, “That’s enough” provides balance and benefit. Our participation would help to smooth out the highs and lows – and give us an opportunity to show off our wardrobes.

After a highly successful career in business, including 26 years with PotashCorp where she was Senior Vice-President, Betty-Ann retired in 2007, the same year that she was named to Canada‘s Most Powerful Women: Top 100 Hall of Fame™. She now works as a speaker, author and mentor and is committed to using her personal and professional experiences to inspire and empower other women.  A firm believer in the value women bring to organizations, Betty-Ann explores changing perceptions of male and female roles including candid observations about what she calls “Good Gender Physics” on her blog at www.stillettochick.com. She helps both men and women understand the primary energy of their gender but also accept and appreciate the strengths of their opposite.

Be the first to comment - What do you think?
Posted by - January 5, 2012 at 4:48 am

Categories: Biotech Chronology   Tags: , ,

Biotechnology Timeline: Important Events And Discoveries In Biotechnology

Biotechnology Timeline: Important Events And Discoveries In Biotechnology

Article by George Royal

1977:

The Age of biotechnology arrives with “somatostatin” – a human growth hormone-releasing inhibitory factor, the first human protein manufactured in bacteria by Genentech, Inc. A synthetic, recombinant gene was used to clone a protein for the first time.

1978:

Genentech, Inc. and The City of Hope National Medical Center announce the successful laboratory production of human insulin using recombinant DNA technology. Hutchinson and Edgell show it is possible to introduce specific mutations at specific sites in a DNA molecule.

1979:

Sir Walter Bodmer suggests a way of using DNA technology to find gene markers to show up specific genetic diseases and their carriers. John Baxter reports cloning the gene for human growth hormone.

1980:

The prokaryote model, E. coli, is used to produce insulin and other medicine, in human form. Researchers successfully introduce a human gene – one that codes for the protein interferon- into a bacterium. The U.S. patent for gene cloning is awarded to Cohen and Boyer.

1981:

Scientists at Ohio University produce the first transgenic animals by transferring genes from other animals into mice. The first gene-synthesizing machines are developed. Chinese scientists successfully clone a golden carp fish.

1982:

Genentech, Inc. receives approval from the Food and Drug Administration to market genetically engineered human insulin. Applied Biosystems, Inc. introduces the first commercial gas phase protein sequencer.

1983:

The polymerase chain reaction is invented by Kary B Mullis. The first artificial chromosome is synthesized, and the first genetic markers for specific inherited diseases are found.

1984:

Chiron Corp. announces the first cloning and sequencing of the entire human immunodeficiency virus (HIV) genome. Alec Jeffreys introduces technique for DNA fingerprinting to identify individuals. The first genetically engineered vaccine is developed.

1985:

Cetus Corporation’s develops GeneAmp polymerase chain reaction (PCR) technology, which could generate billions of copies of a targeted gene sequence in only hours. Scientists find a gene marker for cystic fibrosis on chromosome number 7.

1986:

The first genetically engineered human vaccine – Chiron’s Recombivax HB – is approved for the prevention of hepatitis B. A regiment of scientists and technicians at Caltech and Applied Biosystems, Inc. invented the automated DNA fluorescence sequencer.

1987:

The first outdoor tests on a genetically engineered bacterium are allowed. It inhibits frost formation on plants. Genentech’s tissue plasminogen activator (tPA), sold as Activase, is approved as a treatment for heart attacks.

1988:

Harvard molecular geneticists Philip Leder and Timothy Stewart awarded the first patent for a genetically altered animal, a mouse that is highly susceptible to breast cancer

1989:

UC Davis scientists develop a recombinant vaccine against the deadly rinderpest virus. The human genome project is set up, a collaboration between scientists from countries around the world to work out the whole of the human genetic code.

1990:

The first gene therapy takes place, on a four-year-old girl with an immune-system disorder called ADA deficiency. The human genome project is formally launched.

1991:

Mary-Claire King, of the University of California, Berkeley, finds evidence that a gene on chromosome 17 causes the inherited form of breast cancer and also increases the risk of ovarian cancer. Tracey the first transgenic sheep is born.

1992:

The first liver xenotransplant from one type of animal to another is carried out successfully. Chiron’s Proleukin is approved for the treatment of renal cell cancer.

1993:

The FDA declares that genetically engineered foods are “not inherently dangerous” and do not require special regulation. Chiron’s Betaseron is approved as the first treatment for multiple sclerosis in 20 years.

1994:

The first genetically engineered food product, the Flavr Savr tomato, gained FDA approval. The first breast cancer gene is discovered. Genentech’s Nutropin is approved for the treatment of growth hormone deficiency.

1995:

Researchers at Duke University Medical Center transplanted hearts from genetically altered pigs into baboons, proving that cross-species operations are possible. The bacterium Haemophilus influenzae is the first living organism in the world to have its entire genome sequenced.

1996:

Biogen’s Avonex is approved for the treatment of multiple sclerosis. The discovery of a gene associated with Parkinson’s disease provides an important new avenue of research into the cause and potential treatment of the debilitating neurological ailment.

1997:

Researchers at Scotland’s Roslin Institute report that they have cloned a sheep–named Dolly–from the cell of an adult ewe. The FDA approves Rituxan, the first antibody-based therapy for cancer.

1998:

The first complete animal genome the C.elegans worm is sequenced. James Thomson at Wisconsin and John Gearhart in Baltimore each develop a technique for culturing embryonic stem cells.

1999:

A new medical diagnostic test will for the first time allow quick identification of BSE/CJD a rare but devastating form of neurologic disease transmitted from cattle to humans.

2000:

“Golden Rice,” modified to make vitamin A. Cloned pigs are born for the first time in work done by Alan Coleman and his team at PPL, the Edinburgh-based company responsible for Dolly the sheep.

2001:

The sequence of the human genome is published in Science and Nature, making it possible for researchers all over the world to begin developing genetically based treatments for disease.

2002:

Researchers sequence the DNA of rice, and is the first crop to have its genome decoded.

2003:

The sequencing of the human genome is completed.

Biotechnology HQ: articles and information about the science of biotechnology.










Be the first to comment - What do you think?
Posted by - January 5, 2012 at 1:01 am

Categories: Important Events And Discoveries In Biotechnology   Tags: , , , ,

What’s Biotechnology?

What’s Biotechnology?
Biotechnology is the buzz nowadays. It is being used in the majority of the technology discoveries. Many of us have been told about biotechnology though not every one knows what it exactly is. A layman’s rationalization of biotechnology is using the living organisms and their products to create something new.

While many think of biotechnology as a recent concept, this is not true. As a matter of fact, biotechnology has been in use ever since then. Take the example of agriculture, where in seeds ( part of a living organism ) are used to grow crops. Animal husbandry is also a form of biotechnology where in animas are reared for the production of food.

However, the real development in biotechnology came with the discovery of micro-organisms. The discovery of these organisms in turn led straight to the discovery of how they could be employed in antibiotics and immunization for assorted contagions. This was followed by the discovery of DNA and enzymes, which propelled the utilisation of biotechnology further. Today, scientists can manipulate the construction of enzymes for assorted specific purposes.

In the modern day scenario, biotech isn’t just restricted to the field of agricultural or medical sciences. The field has found its place in the economic sector too. Numerous biochemicals gleaned from plants are employed in various industries for different purposes. These chemicals aren’t just utilized in the food and chemical industry but in the cosmetic industry too. As an example, there are that many plant extracts utilized in assorted anti acne creams. Even popular products like Exposed Skin Care System utilize plant extracts to offer solution to troublesome skin.

Another massive field where you’ll see the utilization of biotechnology is the food industry. It is used to improve the standard of crop, increase the resistance of the plants towards pests and also reinforce the quality of food chemicals. This technology has a good distance to go, as scientists are attempting to discover an in built bio-indicator that would spot food contamination in packed food. The wines of best quality also use biotechnology for production.

The environmental arena is using biotechnology to restore contaminated soil, air and water too. It’s also being employed to treat industrial effluents and risks. What’s more, biotech is habitually getting used to treat brown fields for redevelopment. It is acknowledged as a safer method of pest management too.

At its current pace of development, it seems that biotechnology will shortly take over every area of life. We shall must wait and see the big selection of benefits this technology takes along for the human species.

Here is some more information on Exposed Skin Care System and Best Quality Wines.

Question by Ryan V: is it legal? is it balanced? how does it make you feel?
Imagine hearing the following financial news; “Today, the market in sow bellies is down, soybeans are stable, and the market in human embryos is up.” Recent developments in embryonic research have moved us one step closer to that scenario.

The Jones Institute for Reproductive Medicine in Virginia announced last week that they intentionally created human embryos from donor eggs and sperm with the sole purpose of conducting destructive research on nascent humans. The twelve egg donors were paid $ 1500 to $ 2000 each, about what the average egg donor receives. The sperm donors were paid about $ 50 each. So, that means that the money earned from the destruction of human offspring can pay a month’s house mortgage for a woman and dinner for two for a man.

In a second case, Massachusetts-based company Advanced Cell Technology (ACT) admitted it was attempting to clone human embryos for the purposes of harvesting stem cells from those embryos. ACT is a privately-funded, for-profit biotechnology industry leader.
Associated Press biotechnology writer Paul Elias broke the story on Friday, July 13th, that the Jones Institute, ACT, and Geron Inc., a Menlo Park, California, biotechnology company are racing to develop large numbers of embryonic stem cells to supply a market they hope will open up as soon as President Bush makes up his mind about federal funding for embryonic stem cell research.

Elias claims that “Geron buys leftover frozen embryos from fertility clinics and cracks them open to obtain the stem cells.”

A market in human beings is not a future possibility, it is a present reality. What these companies are doing can only be described as human embryo farming: producing human embryos for a biotechnological research harvest. Only, instead of “farming,” we really ought to call it “pharming” since what they hope to do is to be the first to make a claim on a pharmaceutical treatment that will earn huge profits.
Of course the morning “pharm report” won’t be announcing that the market in embryos is gaining strength-that would be too traumatic for most Americans. Instead, ACT’s ethics committee suggests that a human embryo cloned for research purposes should be called an “activated egg” or “ovasome.”

What they call their “crop” or “product” is a very important marketing decision. The fertility drug Pergonal, for instance, would not likely be as popular if it were called what it is, “Derivative of Urine.” Market share will not rise as high if their product’s name is off-putting or offensive. “Ovasome” sounds like a breakfast drink to be mixed with milk. “I’ll just have ‘Ovasome’,” you can imagine Dad saying as he comes down the stairs in the morning.

Make no mistake about it, this is not silly, it’s dangerous. Human beings and their body parts are being bought and sold, created and destroyed, planted and harvested, for profit or potential profit. Human beings and their parts have become commodities, like sow bellies, corn and soybeans.

In their recent book, Body Bazaar: The Market for Human Tissues in the Biotechnology Age, Lori Andrews and Dorothy Nelkin argue that the value of human body tissue in the biotechnology age–and the potential for profitable patents derived from it–encourages doctors and researchers to think about people differently . . . Body parts are extracted like a mineral, harvested like a crop, or mined like a resource.”
Do we really want to view human embryos as either farms or pharms, especially when the harvesting requires the destruction of the embryo? It’s one thing to use umbilical cords retrieved after the birth of a baby for research, it’s another thing to remove the baby’s life-giving tissues for potential profitable pharmaceuticals. Yet the “pharmers” at Jones Institute, ACT and Geron are encouraging us to commodify tiny humans. These nascent human beings are being imperiled by our own biotechnological avarice. “Biotechnological uses,” say Andrews and Nelkin, “risk running roughshod over social values and personal beliefs.” Indeed.

Americans should repudiate the commodification of human embryos. They are not crops to be harvested. They are not “pharms” to be cultivated. After all, hard as it is to believe, you and I were once tiny human embryos. Didn’t we have a right not to be bought and sold at the “pharmers market?”

Best answer:

Answer by editor@bcdisabilities.com
Why the ‘sanctity of life’ spiel over this and not at the homelessness and other toxic conditions America has created in Iraq over their illegal war?

When you incarcerate the Busher and his Bush Leaguers as the war criminals they are – and that evil troll Hate-me Hank Kissinger – I will try to care about your issue.

… Can’t help feeling it’s only really your own people you care about here – not about those whose poverty is exploited to provide wealthy Americans with, say, healthy pink livers and kidneys and so on. …

Give your answer to this question below!

1 comment - What do you think?
Posted by - January 2, 2012 at 4:45 am

Categories: Plant Biotechnology Books   Tags: ,

« Previous PageNext Page »